For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Rempex Pharmaceuticals, Inc.

USPTO Granted Patents = 27

% Expired Patents = 33.3

CIPO Patents = 1

EPO Patents = 8

Forward Citations = 404

Loading Chart...

Loading Chart...

31 inventors (with patents filed for the assignee):

Scott J Hecker (20 out of 63 patents)

Raja K Reddy (14 out of 31 patents)

Maxim Totrov (14 out of 23 patents)

4. Serge H Boyer (13 out of 47 patents)

5. Olga Rodny (12 out of 27 patents)

6. David C Griffith (12 out of 36 patents)

7. Michael N Dudley (11 out of 36 patents)

8. Tomasz W Glinka (11 out of 33 patents)

9. Gavin C Hirst (8 out of 33 patents)

10. Keith A Bostian (3 out of 17 patents)

11. Robert Higuchi (2 out of 21 patents)

12. Olga Lomovskaya (2 out of 19 patents)

13. Brian Walter Eastman (2 out of 34 patents)

14. David Mark Wallace (2 out of 119 patents)

15. Mark William Surber (1 out of 37 patents)

Core Competencies:

Boronates

Cyclic Boronic Acid Esters

Pharmaceutical Compositions

Tetracycline

Bacterial Efflux Pump Inhibitors

Therapeutic Uses

Synthesis

Salts

Polymorphs

Aminoglycosides

Heterocyclic Compounds

Quaternary Alkyl Ammonium

27 patents: Sort by Forward Citations

1. 10669292 - Synthesis of boronate salts and uses thereof (2020-06-02),

2. 10639318 - Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives (2020-05-05),

3. 10561675 - Cyclic boronic acid ester derivatives and therapeutic uses thereof (2020-02-18),

4. 10385074 - Synthesis of boronate salts and uses thereof (2019-08-20),

5. 10364257 - Apparatus and continuous flow process for production of boronic acid derivatives (2019-07-30),

6. 10183034 - Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives (2019-01-22),

7. 10172874 - Pharmaceutical compositions comprising cyclic boronic acid ester derivatives (2019-01-08),

8. 10004758 - Cyclic boronic acid ester derivatives and methods of making the same (2018-06-26),

9. 9963467 - Boronic acid derivatives and therapeutic uses thereof (2018-05-08),

10. 9744179 - Tetracycline compositions (2017-08-29),

11. 9694025 - Cyclic boronic acid ester derivatives and therapeutic uses thereof (2017-07-04),

12. 9687497 - Salts and polymorphs of cyclic boronic acid ester derivatives and therapeutic uses thereof (2017-06-27),

13. 9642869 - Boronic acid derivatives and therapeutic uses thereof (2017-05-09),

14. 9296763 - Cyclic boronic acid ester derivatives and therapeutic uses thereof (2016-03-29),

15. 9278105 - Tetracycline compositions (2016-03-08),

Company Overview

Rempex Pharmaceuticals, Inc. is a biopharmaceutical company based in San Diego, California, focused on developing innovative therapies for serious infections caused by multidrug-resistant bacteria. The company specializes in the research and development of novel antibiotic treatments, leveraging advanced scientific techniques to address unmet medical needs in infectious disease management. Rempex aims to improve patient outcomes through its commitment to addressing the challenges posed by antibiotic resistance.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

27 Patents

#221 in San Diego, CA

#2,932 in California

#12,420 in US

#24,012 in the World

San Diego, CA, United States of America

Rempex Pharmaceuticals, Inc.

Forward Citations = 404

31 inventors:

Scott J Hecker (20 out of 63 patents)

Raja K Reddy (14 out of 31 patents)

Maxim Totrov (14 out of 23 patents)

4. Serge H Boyer (13 out of 47 patents)

5. Olga Rodny (12 out of 27 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Rempex Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/rempex-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…